Viewing Study NCT00805233


Ignite Creation Date: 2025-12-25 @ 2:56 AM
Ignite Modification Date: 2026-03-01 @ 6:15 AM
Study NCT ID: NCT00805233
Status: COMPLETED
Last Update Posted: 2011-07-22
First Post: 2008-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration
Sponsor: Oregon Health and Science University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Age-Related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neovascular View
None AMD View
None Treatment View
None Lucentis View
None Bromfenac View